Insight on USFDA approval of pralsetinib to treat non-small lung cancer
Blueprint Medicines Corporation, a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that the U.S.... Read More
What is hybrid clinical trial?
Posted on15 Sep 2020
Comments0
A hybrid trial is a type of clinical trial which includes both traditional and pragmatic clinical trial elements. Randomized controlled trials are generally... Read More
Strides Pharma to acquire 54% stake in SteriScience
Posted on15 Sep 2020
Comments0
Strides Pharma Science will invest Rs 135 crore over the next 24 months to acquire around 54 percent stake in SteriScience Pharma... Read More
Aurobindo Pharma partners with BIRAC to develop Covid-19 vaccine
Aurobindo Pharma is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate is based on a... Read More
Insight on First approved COVID-19 vaccine Sputnik V
Posted on11 Aug 2020
Comments0
Russia has announced the launch of first approved covid-19 vaccine. The Covid-19 vaccine brand name is Sputnik V. Sputnik V is developed... Read More
Lupin gets exclusive rights to market and distribute 2 complex injectable assets from ForDoz Pharma
Pharma major Lupin Limited announced that its US based wholly-owned subsidiary Lupin Pharmaceuticals Inc., has entered into an agreement with ForDoz Pharma... Read More
Lynk Pharmaceuticals enters exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA
Lynk Pharmaceuticals (Hangzhou, China) is pleased to announce exclusive licensing agreements with Kobe University (Kobe, Japan) and with RIKEN Research Institute (Saitama,... Read More
Novavax, FDB agreement for large scale manufacturing of COVID-19 vaccine candidate
Posted on28 Jul 2020
Comments0
NovavaxInc, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and FUJIFILM Diosynth Biotechnologies (FDB), a world leading CDMO for... Read More
Pfizer-BioNTech agreement with U.S. Gov for up to 600 million doses of mRNA-based vaccine aandidate against SARS-CoV-2
Pfizer Inc. and BioNTech SE announced the execution of an agreement with the U.S. Department of Health and Human Services and the... Read More
Insight on Novartis’s first-of-its-kind not-for-profit medicine portfolio for symptomatic treatment of COVID-19
Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medicines to treat the major... Read More